Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-25 @ 5:21 PM
Study NCT ID:
NCT00952003
Status:
COMPLETED
Last Update Posted:
2020-11-30
First Post:
2009-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-03
First Submit QC Date:
None
Study First Post Date:
2009-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-26
Last Update Post Date:
2020-11-30
Last Update Post Date Type:
ACTUAL